MaxCyte Inc. (MXCT)
MaxCyte Statistics
Share Statistics
MaxCyte has 106.31M shares outstanding. The number of shares has increased by 1.42% in one year.
| Shares Outstanding | 106.31M |
| Shares Change (YoY) | 1.42% |
| Shares Change (QoQ) | 0.52% |
| Owned by Institutions (%) | 68.96% |
| Shares Floating | 97.95M |
| Failed to Deliver (FTD) Shares | 390 |
| FTD / Avg. Volume | 0.06% |
Short Selling Information
The latest short interest is 3.48M, so 3.28% of the outstanding shares have been sold short.
| Short Interest | 3.48M |
| Short % of Shares Out | 3.28% |
| Short % of Float | 3.31% |
| Short Ratio (days to cover) | 4.82 |
Valuation Ratios
The PE ratio is -10.62 and the forward PE ratio is -9.47. MaxCyte's PEG ratio is -1.97.
| PE Ratio | -10.62 |
| Forward PE | -9.47 |
| PS Ratio | 11.29 |
| Forward PS | 2.4 |
| PB Ratio | 2.11 |
| P/FCF Ratio | -14.91 |
| PEG Ratio | -1.97 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for MaxCyte.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.88, with a Debt / Equity ratio of 0.09.
| Current Ratio | 10.88 |
| Quick Ratio | 10.32 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | -0.39 |
| Debt / FCF | -0.62 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $338.83K |
| Profits Per Employee | $-360.13K |
| Employee Count | 114 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 0.8 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -24.87% in the last 52 weeks. The beta is 1.21, so MaxCyte's price volatility has been higher than the market average.
| Beta | 1.21 |
| 52-Week Price Change | -24.87% |
| 50-Day Moving Average | 3.04 |
| 200-Day Moving Average | 3.84 |
| Relative Strength Index (RSI) | 50.47 |
| Average Volume (20 Days) | 628.95K |
Income Statement
In the last 12 months, MaxCyte had revenue of 38.63M and earned -41.05M in profits. Earnings per share was -0.39.
| Revenue | 38.63M |
| Gross Profit | 31.53M |
| Operating Income | -51.2M |
| Net Income | -41.05M |
| EBITDA | -46.41M |
| EBIT | -51.2M |
| Earnings Per Share (EPS) | -0.39 |
Balance Sheet
The company has 27.88M in cash and 18.03M in debt, giving a net cash position of 9.85M.
| Cash & Cash Equivalents | 27.88M |
| Total Debt | 18.03M |
| Net Cash | 9.85M |
| Retained Earnings | -216.85M |
| Total Assets | 239.47M |
| Working Capital | 155.91M |
Cash Flow
In the last 12 months, operating cash flow was -27.61M and capital expenditures -1.65M, giving a free cash flow of -29.26M.
| Operating Cash Flow | -27.61M |
| Capital Expenditures | -1.65M |
| Free Cash Flow | -29.26M |
| FCF Per Share | -0.28 |
Margins
Gross margin is 81.62%, with operating and profit margins of -132.54% and -106.29%.
| Gross Margin | 81.62% |
| Operating Margin | -132.54% |
| Pretax Margin | -106.29% |
| Profit Margin | -106.29% |
| EBITDA Margin | -120.14% |
| EBIT Margin | -132.54% |
| FCF Margin | -75.75% |
Dividends & Yields
MXCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MXCT is $9, which is 216.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $9 |
| Price Target Difference | 216.9% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 4.55 |
| Piotroski F-Score | 3 |